logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Panos Kanavos

Department of Health Policy

53H指数
384论文数
9.3K被引数
收录论文 108
发表时间
logo
Implementing sustainable liver health in Europe: a second EASL–Lancet Commission在欧盟实施可持续肝脏健康：第二次EASL–Lancet委员会
errThe Lancet
IF88.5
err2026-04-29
err0
PREAI
errTom H Karlsen; Sharon J Hutchinson; Shira Zelber-Sagi; Patrizia Carrieri; Francesco Negro; Aaron G Lim; Michele Cecchini; M Ashworth Dirac; Frank Murray; Eivind Engebretsen; Erika Duffell; Georg Schomerus; Kristin Voigt; Petter Bae Brandtzaeg; Alienor Lerouge; Panos Kanavos; Luca Pani; Devin Razavi-Shearer; Million Tesfaye Eshete; Sabine Vuik
err分享
err收藏
Mapping the landscape of managed entry agreements: a systematic review of global frameworks; system-level components; and implementation challenges规划管理进入协议的前景: 对全球框架的系统审查; 系统级组件; 和实施挑战
errFrontiers in Pharmacology
IF4.8
err2026-04-20
err0
errOAAI
errHA Hussain Abdulrahman Al-Omar †; AA Asma Abdulaziz Almuhsin †; LH Lolwa Hamad Almudaiyan †; AH Amal Hassan Al-Najjar †; LC Laila Carolina Abu Esba †; HA Hind Almodaimegh †; JA Jehan Alamre †; CC Consuela Cheriece Yousef †; MA Mansoor Ahmed Khan †; KA Khalid AlYahya †; ES Esraa S. Altawil †; AS Abdualmajeed Saad Binjumayah; FA Faisal Awwadh Alharbi; ST Sultan Tawfiq AlShurbaji †; FM Fatma Maraiki †; JE Jaime Espín †; RT Rosanna Tarricone †; PK Panos Kanavos †
err分享
err收藏
A Delphi study on valuing DNA sequencing in oncology: a European stakeholder developed framework for assessing next generation sequencing and comprehensive genomic profiling diagnostics关于在肿瘤学中评估DNA测序价值的德尔菲研究：由欧洲利益相关者开发的评估下一代测序和综合基因组分析诊断的框架
erreBioMedicine
IF10.8
err2025-10-16
err0
errOAAI
errAugustovski Federico; Chavez Danitza; Haig Madeleine; Main Caitlin; Argento Fernando; Colaci Carla; Mills Mackenzie; Alfie Verónica; Pichon-Riviere Andrés; Alcaraz Andrea; Kanavos Panos
err分享
err收藏
Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries为何药物未能通过卫生技术评估：对七个经合组织国家卫生技术评估拒绝案例的比较分析
errHEALTH ECONOMICS POLICY AND LAW
IF3.3
err2025-09-01
err0
errOAAI
errPapadopoulos, Filippos; Visintin, Erica; Kyriopoulos, Ilias; Kanavos, Panos
err分享
err收藏
A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia-results from a multi-stakeholder workshop一个战略框架，用于协同沙特阿拉伯获取药品的准入协议努力——多利益相关方研讨会的结果
errJOURNAL OF MEDICAL ECONOMICS
IF3
err2025-05-21
err0
errOAAI
errHussain Abdulrahman Al-Omar; Asma Abdulaziz Almuhsin; Lolwa Hamad Almudaiyan; Amal Hassan Al-Najjar; Laila Carolina Abu Esba; Hind Almodaimegh; Esraa S. Altawil; Consuela Cheriece Yousef; Mansoor Ahmed Khan; Khalid AlYahya; Jehan Alamre; Fatma Maraiki; Jaime Espín; Rosanna Tarricone; Panos Kanavos
err分享
err收藏
An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries分销薪酬和税收政策对处方药最终价格影响的评估: 来自35个国家的证据
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2024-09-19
err0
errOAAI
errLeon, Giovanny; Carbonel, Christophe; Rampuria, Aparajit; Rajpoot, Ravindra Singh; Joshi, Parth; Kanavos, Panos
err分享
err收藏
A Systematic Review of Value Criteria for Next-Generation Sequencing/ Comprehensive Genomic Profiling to Inform Value Framework Development系统审查下一代测序/全面基因组分析的价值标准，为价值框架开发提供信息
errVALUE IN HEALTH
IF6
err2024-05-01
err1
errOAAI
errAugustovski, Federico; Colaci, Carla; Mills, Mackenzie; Chavez, Danitza; Argento, Fernando; Alfie, Veronica; Riviere, Andres Pichon; Kanavos, Panos; Alcaraz, Andrea
err分享
err收藏
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe如何改进卫生技术评估以优化药品的获取？来自欧洲德尔菲研究的结果
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2023-11-02
err1
errOAAI
errFontrier, Anna-Maria; Kamphuis, Bregtje; Kanavos, Panos
err分享
err收藏
A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom
errSOCIAL SCIENCE & MEDICINE
IF5
err2023-11-01
err1
errOAAI
errAngelis, A.; Montibeller, G.; Kanavos, P.
err分享
err收藏
Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions评估面向提供者的数字健康技术在慢性病管理中的价值: 基于多利益相关方认知的价值框架
errMEDICAL DECISION MAKING
IF2.3
err2023-10-26
err6
errOAAI
errMain, Caitlin; Haig, Madeleine; Chavez, Danitza; Kanavos, Panos
err分享
err收藏
A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach评估旨在改善慢性病管理的面向患者的数字健康技术的价值框架: Delphi方法
errVALUE IN HEALTH
IF6
err2023-10-01
err9
errOAAI
errHaig, Madeleine; Main, Caitlin; Chavez, Danitza; Kanavos, Panos
err分享
err收藏
Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries卫生技术评估的算法和启发式: 对七个OECD国家新药HTA结果相关因素的回顾性分析
errSOCIAL SCIENCE & MEDICINE
IF5
err2023-08-01
err6
errOAAI
errKanavos, Panos; Visintin, Erica; Gentilini, Arianna
err分享
err收藏
Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?加拿大药品和卫生技术署的报销建议是否转化为加拿大安大略省孤儿药的承保决定？
errVALUE IN HEALTH
IF6
err2023-07-01
err4
errOAAI
errFontrier, Anna-Maria; Kanavos, Panos
err分享
err收藏
Road traffic mortality and economic uncertainty: Evidence from the United States道路交通死亡率和经济不确定性: 来自美国的证据
errSOCIAL SCIENCE & MEDICINE
IF5
err2023-06-01
err3
errOAAI
errKanavos, Panos; Vandoros, Sotiris
err分享
err收藏
How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and CanadaHTA机构如何看待药品的有条件批准？来自英格兰、苏格兰、法国和加拿大的证据
errHEALTH POLICY
IF3.4
err2022-11-01
err7
errOAAI
errMills, Mackenzie; Kanavos, Panos
err分享
err收藏
Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study
errORPHANET JOURNAL OF RARE DISEASES
IF3.5
err2022-09-06
err7
errOAAI
errAngelis, A.; Mellerio, J. E.; Kanavos, P.
err分享
err收藏
Challenges for health systems seeking to embrace virtual health care for population health寻求将虚拟医疗保健用于人口健康的卫生系统面临的挑战
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2022-08-03
err2
errOAAI
errKanavos, Panos; Vogelsang, Michelle; Haig, Madeleine; Kolovou, Vasiliki
err分享
err收藏
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland美国、德国、法国、英国、加拿大、澳大利亚和苏格兰多适应症抗癌药物的价值和价格
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2022-07-11
err33
errOAAI
errMichaeli, Daniel Tobias; Mills, Mackenzie; Kanavos, Panos
err分享
err收藏
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGAFDA，EMA，加拿大卫生部和TGA批准新的靶向癌症药物的初始和补充适应症
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2022-04-07
err30
errOAAI
errMichaeli, Daniel Tobias; Mills, Mackenzie; Michaeli, Thomas; Miracolo, Aurelio; Kanavos, Panos
err分享
err收藏
Pricing of in-patent pharmaceuticals in the Middle East and North Africa: Is external reference pricing implemented optimally?中东和北非专利药品的定价: 外部参考定价是否得到最佳实施？
errHEALTH POLICY
IF3.4
err2020-12-01
err5
errOAAI
errKanavos, Panos; Kamphuis, Bregtje W.; Fontrier, Anna-Maria; Parkin, Georgia Colville; Saleh, Shadi; Akhras, Kasem S.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
V
Vlad Ratziu
H 指数: 107 · 论文数: 695
S
Stephen B. Soumerai
H 指数: 81 · 论文数: 306
M
Mark Thursz
H 指数: 80 · 论文数: 704
D
Dennis Ross‐Degnan
H 指数: 75 · 论文数: 390
P
Pedro Curi Hallal
H 指数: 74 · 论文数: 639
查看更多